[Radiosensitization by double suicide gene system in ACC-2 cell]

Area of Science:

• Oncology
• Molecular Biology
• Radiotherapy

Background:

• Adenoid cystic carcinoma (ACC) is a rare malignancy.
• Gene therapy offers novel treatment strategies for cancer.
• Radiosensitization aims to improve the efficacy of radiation therapy.

Purpose of the Study:

• To evaluate the radiosensitizing effect of a CD-TK double suicide gene therapy system combined with a prodrug in ACC-2 cells.
• To assess the impact of this combined therapy on cancer cell survival under varying conditions.

Main Methods:

• Adenoid cystic carcinoma cells (ACC-2) were transfected with CD and TK genes.
• Stable transfectants were selected and confirmed by RT-PCR.
• Cells were subjected to radiotherapy (0-10 Gy) with or without the prodrug under aerobic and anoxic conditions.
• Cell clone formation assays were used to determine radiosensitization efficacy.

Main Results:

• Successful expression of CD and TK genes in ACC-2 cells was confirmed.
• Radiotherapy significantly reduced colony formation rate in a dose-dependent manner.
• The combination of CD-TK gene therapy and prodrug significantly decreased cell survival fractions compared to control groups in both aerobic and anoxic conditions.
• Aerobic conditions showed a greater reduction in colony formation rate than anoxic conditions.

Conclusions:

• The CD-TK double suicide gene therapy system combined with a prodrug effectively enhances radiosensitivity in ACC-2 cells.
• This combined therapeutic strategy increases the efficacy of X-ray radiation in killing cancer cells.
• The findings suggest a promising approach for improving ACC treatment outcomes.